This may alleviate IBS symptoms by decreasing the production of free radicals and inflammatory mediators like TNF-α and IL-1, along with pro-inflammatory enzymes such as iNOS and COX-2, and reducing activity in inflammatory signalling pathways like NF-kB [54]. This evidence concerns the gene NFKB1 and irritable bowel syndrome.